The effects of silent cerebral ischemic lesions on the prognosis of idiopathic Parkinson's disease

Parkinsonism and Related Disorders

Volumn 19, Issue 8, 2013, Pages 761-763

  Song, In Uk ^a   Kim, Young Do ^a   Cho, Hyun Ji ^a   Chung, Sung Woo ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

Idiopathic Parkinson's disease; Prognosis; Silent ischemic lesions

Indexed keywords

DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA;

AGED; ARTICLE; BRAIN DAMAGE; BRAIN ISCHEMIA; CONTROLLED STUDY; DEGENERATIVE DISEASE; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IDIOPATHIC DISEASE; IDIOPATHIC PARKINSON DISEASE; MAJOR CLINICAL STUDY; MALE; MOTOR DYSFUNCTION; NEUROIMAGING; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; PRIORITY JOURNAL; PROGNOSIS; SILENT CEREBRAL ISCHEMIC LESION; VASCULAR DISEASE;

AGED; BRAIN ISCHEMIA; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PARKINSON DISEASE; PROGNOSIS; SINGLE-BLIND METHOD;

EID: 84879414493     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2013.04.006     Document Type: Article

References (13)

1. Vermeer S.E., Prins N.D., den Heijer T., Hofman A., Koudstaal P.J., Breteler M.M. Silent brain infarcts and the risk of dementia and cognitive decline. NEngl J Med 2003, 348:1215-1222.
2. Santangelo G., Vitale C., Trojano L., De Gaspari D., Bilo L., Antonini A., et al. Differential neuropsychological profiles in Parkinsonian patients with or without vascular lesions. Mov Disord 2010, 25:50-56.
3. Rektor I., Goldemund D., Bednarik P., Sheardova K., Michalkova Z., Telecka S., et al. Impairment of brain vessels may contribute to mortality in patients with Parkinson's disease. Mov Disord 2012, 27:1169-1172.
4. Rektor I., Goldemund D., Sheardova K., Rektorova I., Michalkova Z., Dufek M. Vascular pathology in patients with idiopathic Parkinson's disease. Parkinsonism Relat Disord 2009, 15:24-29.
5. Wong T.Y., Klein R., Sharrett A.R., Couper D.J., Klein B.E., Liao D.P., et al. Cerebral white matter lesions, retinopathy, and incident clinical stroke. JAm Med Assoc 2002, 288:67-74.
6. Lee S.J., Kim J.S., Lee K.S., An J.Y., Kim W., Kim Y.I., et al. The severity of leukoaraiosis correlates with the clinical phenotype of Parkinson's disease. Arch Gerontol Geriatr 2009, 49:255-259.
7. Stern Y. Cognitive reserve and Alzheimer disease. Alzheimer Dis Assoc Disord 2006, 20:S69-S74.
8. Song I.U., Kim J.S., Kim Y.I., Eah K.Y., Lee K.S. Clinical significance of silent cerebral infarctions in patients with Alzheimer disease. Cogn Behav Neurol 2007, 20:93-98.
9. Derejko M., Slawek J., Wieczorek D., Dubaniewicz M., Lass P. The influence of vascular risk factors and white matter hyperintensities on the degree of motor impairment in Parkinson's disease. Neurol Neurochir Pol 2006, 40:276-283.
10. Beyer M.K., Aarsland D., Greve O.J., Larsen J.P. Visual rating of white matter hyperintensities in Parkinson's disease. Mov Disord 2006, 21:223-229.
11. de Laat K.F., van Norden A.G., Gons R.A., van Uden I.W., Zwiers M.P., Bloem B.R., et al. Cerebral white matter lesions and lacunar infarcts contribute to the presence of mild parkinsonian signs. Stroke 2012, 43:2574-2579.
12. Diem-Zangerl A., Seppi K., Oberaigner W., Poewe W. Mortality in Parkinson's disease, a 20-year follow-up study. Mov Disord 2010, 25:661-662.
13. Papapetropoulos S., Ellul J., Argyriou A.A., Talelli P., Chroni E., Papapetropoulos T. The effect of vascular disease on late onset Parkinson's disease. Eur J Neurol 2004, 11:231-235.